Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Molibresib |
Trade Name | |
Synonyms | I-BET762|GSK525762|GSK-525762|GSK 525762 |
Drug Descriptions |
Molibresib (GSK525762) is a JQ1 derivative which binds to the bromodomain of BET proteins preventing their interaction with acetylated histone peptides, thus disrupting chromatin remodeling, gene expression, and cell proliferation (PMID: 24015967, PMID: 30906568, PMID: 32328561). |
DrugClasses | BET Inhibitor (Pan) 32 |
CAS Registry Number | 1260907-17-2 |
NCIT ID | C101538 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Abiraterone + Molibresib | Abiraterone Molibresib | 0 | 1 |
Bortezomib + Molibresib | Bortezomib Molibresib | 0 | 0 |
Carfilzomib + Molibresib | Carfilzomib Molibresib | 0 | 0 |
Enzalutamide + Molibresib | Enzalutamide Molibresib | 0 | 1 |
Fulvestrant + Molibresib | Fulvestrant Molibresib | 0 | 1 |
Molibresib | Molibresib | 0 | 2 |
Molibresib + Paclitaxel + unspecified PD-L1 antibody | Molibresib Paclitaxel unspecified PD-L1 antibody | 0 | 0 |
Molibresib + Palbociclib | Molibresib Palbociclib | 0 | 0 |
Molibresib + Rucaparib | Molibresib Rucaparib | 0 | 0 |
Molibresib + Selumetinib | Molibresib Selumetinib | 0 | 0 |